BEST-CLI
2022
Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia
In 1,830 patients with chronic limb-threatening ischaemia and infra-inguinal disease, surgical bypass reduced major adverse limb events or death compared with endovascular therapy, but only in those with an adequate single-segment great saphenous vein.
Result
Primary endpoint: Composite of major adverse limb event or death from any cause
Cohort 1 (adequate saphenous vein, n=1,434): 42.6 % vs 57.4 % (HR 0.68; 95 % CI 0.59–0.79; p<0.001). Cohort 2 (alternative conduit, n=396): 42.8 % vs 47.7 % (HR 0.79; 95 % CI 0.58–1.06; p=0.12).
- Subtopic
- Revascularisation
- Design
- Open-label RCT with two parallel cohorts
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2024 PAADACC/AHA 2024 PAD
- Source
- Farber A, Menard MT, et al. N Engl J Med. 2022;387(25):2305-2316.doi 10.1056/NEJMoa2207899
Discussion & critique
Enrolment took nine years, so modern below-knee endovascular technology is under-represented, and only cohort 1 is positive. It nevertheless supplies the strongest randomised evidence that a good saphenous vein should push the choice toward bypass in chronic limb-threatening ischaemia.